ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Tennessee » Rheumatology

Top Rheumatology Prescribers in Tennessee

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
AQUEEL KOUSER MD

Rheumatology

8,219

$821K

1008
450 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

42%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 21%

$100
Average prescription price

Avg: $147

VICTOR BYRD M.D.

Rheumatology

7,898

$947K

577
328 are 65+

11%
patients receiving schedule two controlled substances

Avg: 4%

33%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 21%

$120
Average prescription price

Avg: $147

MICHAEL BRIT

Rheumatology

7,647

$489K

619
414 are 65+

4%
patients receiving schedule two controlled substances

Avg: 4%

40%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

13%
prescriptions for brand name drugs

Avg: 21%

$64
Average prescription price

Avg: $147

CHARLES ARKIN M.D.

Rheumatology

7,561

$999K

451
373 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

10%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 21%

$132
Average prescription price

Avg: $147

EMILIO RODRIGUEZ M.D.

Rheumatology

7,209

$490K

478
343 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

7%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 21%

$68
Average prescription price

Avg: $147

SIVALINGAM KANAGASEGAR MD

Rheumatology

7,123

$1.32M

720
405 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

26%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 21%

$185
Average prescription price

Avg: $147

JOSEPH HUFFSTUTTER M.D.

Rheumatology

7,059

$759K

716
561 are 65+

18%
patients receiving schedule two controlled substances

Avg: 4%

16%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 21%

$107
Average prescription price

Avg: $147

JAMES GORE MD

Rheumatology

6,912

$1.07M

576
389 are 65+

2%
patients receiving schedule two controlled substances

Avg: 4%

13%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 21%

$154
Average prescription price

Avg: $147

KENNY SIZEMORE MD

Rheumatology

6,564

$901K

572
378 are 65+

12%
patients receiving schedule two controlled substances

Avg: 4%

24%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 21%

$137
Average prescription price

Avg: $147

CHARLES SIENKNECHT M.D.

Rheumatology

6,509

$969K

657
512 are 65+

24%
patients receiving schedule two controlled substances

Avg: 4%

22%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 21%

$149
Average prescription price

Avg: $147

RICHARD BRACKETT MD

Rheumatology

6,417

$769K

445
316 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

33%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 21%

$120
Average prescription price

Avg: $147

ELIZABETH SIMPSON

Rheumatology

5,994

$728K

682
528 are 65+

14%
patients receiving schedule two controlled substances

Avg: 4%

26%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 21%

$121
Average prescription price

Avg: $147

DAVID LURIE M. D.

Rheumatology

5,851

$1.15M

516
367 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 21%

$196
Average prescription price

Avg: $147

ELIZABETH TURNER

Rheumatology

5,725

$551K

531
327 are 65+

3%
patients receiving schedule two controlled substances

Avg: 4%

27%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 21%

$96
Average prescription price

Avg: $147

WILLIAM CRAIG D.O.

Rheumatology

5,673

$678K

635
507 are 65+

15%
patients receiving schedule two controlled substances

Avg: 4%

20%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 21%

$119
Average prescription price

Avg: $147

JAMES BURNS MD

Rheumatology

5,568

$816K

441
269 are 65+

16%
patients receiving schedule two controlled substances

Avg: 4%

23%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 21%

$147
Average prescription price

Avg: $147

MARVIN MEADORS M.D.

Rheumatology

5,017

$470K

440
332 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

14%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

15%
prescriptions for brand name drugs

Avg: 21%

$94
Average prescription price

Avg: $147

SONG ZANG MD

Rheumatology

4,991

$1.04M

576
393 are 65+

15%
patients receiving schedule two controlled substances

Avg: 4%

35%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 21%

$209
Average prescription price

Avg: $147

MICHAEL WATTERSON MD

Rheumatology

4,840

$445K

386
228 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

28%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 21%

$92
Average prescription price

Avg: $147

ELI STEIGELFEST MD

Rheumatology

4,811

$843K

541
396 are 65+

2%
patients receiving schedule two controlled substances

Avg: 4%

6%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 21%

$175
Average prescription price

Avg: $147

ROBERT LAGRONE MD

Rheumatology

4,347

$1.27M

397
256 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

27%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 21%

$293
Average prescription price

Avg: $147

R COLLINS M.D.

Rheumatology

4,220

$357K

454
336 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

29%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 21%

$85
Average prescription price

Avg: $147

CHRISTOPHER MORRIS MD

Rheumatology

4,167

$667K

701
413 are 65+

3%
patients receiving schedule two controlled substances

Avg: 4%

17%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 21%

$160
Average prescription price

Avg: $147

A. LEAIRD MD

Rheumatology

4,092

$321K

278
181 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

17%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 21%

$78
Average prescription price

Avg: $147

GLENN DOUGLAS MD

Rheumatology

4,010

$671K

407
264 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

23%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 21%

$167
Average prescription price

Avg: $147

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank